Please login first

Journal Cluster Webinar | Cognitive Impairment After Stroke: Current Research Into Neuropathology, Evaluation and Management

Part of the MDPI Journal Cluster Webinar series
26 September 2025, 17:00 (CEST)

Cognition, Stroke, Vascular Cognitive Impairment, Vascular Dementia, Cognitive Assessment, Neuropathology, Imaging Markers, Spatial Neglect, Quality of Life
Bookmark
Bookmark event Remove event from bookmarks
Add this event to bookmarks
Event Registration Contact Us

Webinar Content

In this section, you will find the recordings of this webinar to watch, re-watch and share with your colleagues!
Post-stroke cognitive impairment is increasingly recognized as a major priority in cerebrovascular research due to its high prevalence and life-altering impact. This webinar brings together an international panel of researchers from diverse backgrounds to share recent advancements in the field. Covering topics from neuropathology and risk factors to assessment methods and emerging management strategies, the presentations offer valuable insights for a broad audience, including both researchers and clinicians.

Event Chairs

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada Website

Introduction
Bio
Bogna holds master’s degrees in Psychology and Brain Injury Rehabilitation, with her training and career focused on clinical research in cerebrovascular disease. She completed her PhD in 2021 at the University of Glasgow, where her research investigated the prognosis of cognitive impairment following stroke. Currently, she is a postdoctoral associate in the Department of Clinical Neurosciences at the University of Calgary. Her work integrates both quantitative and qualitative methodologies, with a strong emphasis on patient-centred outcomes.

School of Health Sciences, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, UK Website

Introduction
Bio
Short bio: Emma is a mixed methods researcher with a background in psychology. She has worked in clinical research since 2014, with roles in the NHS, university, and consultancy. Emma completed her PhD at the University of Glasgow which examined measurement properties and diagnostic accuracy of cognitive screening instruments. Prior to joining the University of Manchester, Emma was working as a Senior Research Scientist at Modus Outcomes, a patient centred outcomes research consultancy.

Invited Speakers

Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia

Introduction
Bio
Memory Lucy Mtambo is a PhD candidate at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. She researches post-stroke cognitive impairment in community-dwelling survivors and aims to provide evidence to strengthen prevention and health promotion strategies in rural and remote areas of low- and middle-income countries.

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

Introduction
Talk
Thomas is entering the second year of his MSc in Biomedical Engineering at the University of Calgary, studying under Dr. Philip A. Barber and Dr. M. Ethan MacDonald. His research looks to combine multimodal biomarkers, including MR imaging, blood tests, genotyping, and demographic data, with machine learning to predict late life cognitive decline in stroke patients. Before his master’s, Thomas was a chemical engineer, working in the energy industry for over three years.

Department of Neurology, McGovern Medical School, University of Texas Health Science Center, Houston, United States

Introduction
Bio
Dr. Ritzel conducted his graduate studies on stroke immunology in the Department of Neuroscience at the University of Connecticut Health Center and obtained his PhD in 2016. He then pursued postdoctoral training at the Shock, Trauma and Anesthesiology Research Center at the University of Maryland School of Medicine in Baltimore, where he studied neuroimmune interactions in chronic traumatic brain injury. Dr. Ritzel received the inaugural Michael Shipley Postdoctoral Award for excellence in neuroscience research and has been the recipient of NINDS F31, F32, and K99/R00 training awards. His translational neuroscience laboratory at the University of Texas Health Science Center in Houston is actively investigating the neuroimmune interactions underlying CNS aging, acute brain injury, and chronic neurodegeneration.

Department of Neuropsychology, National Hospital for Neurology and Neurosurgery, University College London Hospitals, London, United Kingdom

Introduction
Bio
Dr. Edgar Chan is a Consultant Clinical Neuropsychologist. He completed his undergraduate degree in Psychology at the University of Melbourne and his post-graduate professional training in Clinical Psychology and Clinical Neuropsychology at the University of Queensland. He obtained a PhD in Cognitive Neuroscience at the Queensland Brain Institute and has been working in the Department of Neuropsychology at the National Hospital for Neurology and Neurosurgery Queen Square since 2013. He is also an Honorary Senior Research Associate with the Stroke Research Group at the Institute of Neurology, UCL.

School of Psychology, University of East Anglia, Norwich, United Kingdom

Introduction
Bio
Dr. Yidian Gao is a postdoctoral researcher with a clinical neuroscience and psychiatry background. Having completed her doctoral and master’s studies at Second Xiangya Hospital, China, Yidian’s primary research interest lies in utilizing multi-site neuroimaging data to generate more robust, generalizable insights for clinical neuroscience challenges, such as conduct disorder and mild traumatic brain injury. In her recent work, she has led and contributed to international collaborations (including ENIGMA-Antisocial Behavior and mTBI-PREDICT), focusing on data harmonization and open-science practices. Ultimately, Yidian aims to translate these large-scale, multi-modal findings into meaningful clinical applications that can enhance patient outcomes and inform future interventions.

Program

Speaker/Presentation Time in CEST Time in EDT

Dr. Bogna Anna Drozdowska & Dr. Emma Elliott (Chair)

Chair Introduction
5:00 - 5:10 pm 11:00 - 11:10 am

Ms. Memory Lucy Mtambo (Speaker 1)

The Impact of Stroke on Cognitive Function and Quality of Life among Community Survivors
5:10 - 5:25 pm 11:10 - 11:25 am

Mr. Thomas Oldreive (Speaker 2)

MRI Biomarkers of Cognition in Transient Ischemic Attack
5:25 - 5:40 pm 11:25 - 11:40 am

Dr. Rodney Ritzel (Speaker 3)

Neuropathological Hallmarks during the Chronic Phase of Ischemic Stroke in Mice and Humans

5:40 - 6:05 pm

11:40 am - 12:05 pm

Dr. Edgar Chan (Speaker 4)

Queen Square Cognitive Screen (Q-CAS) – Validation in Stroke

6:05 - 6:20 pm

12:05 - 12:20 pm

Dr. Yidian Gao (Speaker 5)

Spatial Inattention Grasping Therapy (SIGHT) for Rehabilitation of Spatial Neglect Post-Stroke: A Randomised-Controlled Multicentre Efficacy Trial with Embedded Mechanistic Study of Determinants of Therapy Response

6:20 - 6:45 pm

12:20 - 12:45 pm

Dr. Bogna Anna Drozdowska & Dr. Emma Elliott (Chair)

Closing of Webinar

6:45 – 6:50 pm

12:45 - 12:50 pm

Sponsors and Partners

Organizers

Top